CLINICAL TRIALS PROFILE FOR HEC96719
✉ Email this page to a colleague
Clinical Trials for HEC96719
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT04194242 ↗ | The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects | Completed | Sunshine Lake Pharma Co., Ltd. | Phase 1 | This study is a safety, tolerability, and pharmacokinetics phase Ⅰstudy of HEC96719, in healthy subjects.This study is the healthy adult subjects single ascending-dose research |
NCT04422496 ↗ | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects | Completed | Sunshine Lake Pharma Co., Ltd. | Phase 1 | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Non-alcoholic fatty liver disease (NAFLD) treatment drug HEC96719 in Healthy Male and Female Subjects |
NCT04546984 ↗ | Multiple Dose Safety, Tolerability, PK,PD and Food Effect Study of HEC96719 in Healthy Adult Subjects | Completed | Sunshine Lake Pharma Co., Ltd. | Phase 1 | The Safety, Tolerability, Pharmacokinetic, Pharmacodynamics and Food Effect Study of HEC96719 in Healthy Subjects |
NCT05397379 ↗ | A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis | Recruiting | Sunshine Lake Pharma Co., Ltd. | Phase 2 | This is a Phase 2, randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, efficacy, and pharmacokinetics of HEC96719 in non-cirrhotic NASH patients. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for HEC96719
Condition Name
Clinical Trial Locations for HEC96719
Clinical Trial Progress for HEC96719
Clinical Trial Phase
Clinical Trial Sponsors for HEC96719
Sponsor Name